Literature DB >> 28729076

Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson's disease in the North-eastern Han Chinese population.

Xiaoyuan Li1, Li Xue2, Jinfang Sun3, Yanping Sun4, Anmu Xie5.   

Abstract

Growing evidences suggested that inflammatory process played a critical role in the pathogenesis of Parkinson's disease (PD). Given that TLR2 has been implicated in the perpetuation of inflammatory responses in the central nervous system (CNS), we investigated the association between two genetic variants (rs3804099 and rs3804100) of TLR2 and sporadic PD in Han Chinese population. 395 Han Chinese sporadic PD patients and 413 healthy age and gender-matched controls were genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The sporadic PD patients showed a higher T allele frequency than the healthy-matched control (p=0.019). Furthermore rs3804099 dominate model TT versus (vs.) TC+CC increase the risk of sporadic PD (OR=1.376, 95%CI=1.043-1.814, p=024). From the subgroup analysis, the variant allele T of rs3804099 was higher in sporadic PD cases (73.1%) than in controls (67.4%) in the late-onset cohort. Meanwhile rs3804099 revealed significant association in dominant model: Subjects with TT genotypes vs. those with TC+CC genotype showed evident significant in late-onset cohort (LOPD OR=1.417, 95%CI=1.051-1.911, p=022). In contrast, allele frequencies at rs3804100 were similar between patients and controls. Taken together, this study reveals that polymorphism of TLR2 locus is associated with risk of sporadic PD in the North-eastern part of Han Chinese population. Further studies are required to evaluate the association.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Parkinson’s disease (PD); Single nucleotide polymorphisms (SNPs); Toll-like receptor 2 (TLR2)

Mesh:

Substances:

Year:  2017        PMID: 28729076     DOI: 10.1016/j.neulet.2017.07.014

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

Review 1.  The role of Toll-like receptors and neuroinflammation in Parkinson's disease.

Authors:  Arash Heidari; Niloufar Yazdanpanah; Nima Rezaei
Journal:  J Neuroinflammation       Date:  2022-06-06       Impact factor: 9.587

2.  Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation.

Authors:  Changyoun Kim; Brian Spencer; Edward Rockenstein; Hodaka Yamakado; Michael Mante; Anthony Adame; Jerel Adam Fields; Deborah Masliah; Michiyo Iba; He-Jin Lee; Robert A Rissman; Seung-Jae Lee; Eliezer Masliah
Journal:  Mol Neurodegener       Date:  2018-08-09       Impact factor: 14.195

Review 3.  Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies.

Authors:  Somin Kwon; Michiyo Iba; Eliezer Masliah; Changyoun Kim
Journal:  Exp Neurobiol       Date:  2019-10-31       Impact factor: 3.261

4.  Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease.

Authors:  Anastazja M Gorecki; Megan C Bakeberg; Frances Theunissen; Jade E Kenna; Madison E Hoes; Abigail L Pfaff; P Anthony Akkari; Sarah A Dunlop; Sulev Kõks; Frank L Mastaglia; Ryan S Anderton
Journal:  Front Aging Neurosci       Date:  2020-11-17       Impact factor: 5.750

Review 5.  Intestinal Inflammation and Parkinson's Disease.

Authors:  Yu Li; Yuanyuan Chen; Lili Jiang; Jingyu Zhang; Xuhui Tong; Dapeng Chen; Weidong Le
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

Review 6.  Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.

Authors:  Marcell P Szabo; Michiyo Iba; Avindra Nath; Eliezer Masliah; Changyoun Kim
Journal:  Exp Mol Med       Date:  2022-04-08       Impact factor: 12.153

7.  Association of ATG5 gene polymorphism with Parkinson's disease in a Han Chinese population.

Authors:  Jing Han; Ganghua Feng; Jibao Wu; Yi Zhang; Zhipeng Long; Xiaoxi Yao
Journal:  Acta Neurol Belg       Date:  2021-10-18       Impact factor: 2.471

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.